摘要
冠心病是我国居民致残、致死的重要原因之一,冠心病的主要死因是急性冠脉综合征。急性冠脉综合征是一系列病因相同,但病情严重程度、治疗方法和预后差别很大的疾病谱。对非ST段抬高急性冠脉综合征进行危险分层和个体化治疗已成为共识。本文对最近发表的中华心血管病学会非ST段抬高急性冠脉综合征诊治指南,并结合欧洲心脏病学会、美国心脏病学会指南进行解读。
Cardiovascular diseases are currently among the leading cause of death in China. Among these, acute coronary syndrome is the most prevalent manifestation and is associated with high mortality and morbidity. It is well established that acute coronary syndromes in their different clinical presentations share a widely common pathophysiological substrate criteria for risk stratification have been developed to allow the clinician to make timely decisions on pharmacological man- agement as well as coronary revascularization strategies, tailored to the individual patient. In this paper, we review Chi- nese Society of Cardiology, ESC and AHA/ACCF Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST--segment elevation.
出处
《医学与哲学（B）》
2012年第8期13-16,24,共5页
Medicine & Philosophy(B)
